Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 283541 - 283560 out of 488868 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Italy | (L01EG02) everolimus (neoplastic diseases) | AFINITOR*30 cpr 10 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NOVARTISEUROPHARMLTD |
| Italy | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS*30 cpr 10 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | ETHYPHARMS.A. |
| Italy | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS*30 cpr 10 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | MEDACPHARMASrl |
| Italy | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS*30 cpr 10 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | SANDOZGMBH |
| Italy | (L01EG02) everolimus (neoplastic diseases) | VOTUBIA*30 cpr dispers 2 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Tuberous Sclerosis | NOVARTISEUROPHARMLTD |
| Italy | (L01EG02) everolimus (neoplastic diseases) | VOTUBIA*30 cpr dispers 3 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Tuberous Sclerosis | NOVARTISEUROPHARMLTD |
| Italy | (L01EG02) everolimus (neoplastic diseases) | AFINITOR*30 cpr 5 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NOVARTISEUROPHARMLTD |
| Italy | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS*30 cpr 5 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | ETHYPHARMS.A. |
| Italy | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS*30 cpr 5 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | MEDACPHARMASrl |
| Italy | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS*30 cpr 5 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | SANDOZGMBH |
| Italy | (L01EH01) lapatinib | TYVERB*70 cpr riv 250 mg flacone | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | NOVARTISEUROPHARMLTD |
| Italy | (L01EH01) lapatinib | TYVERB*84 cpr riv 250 mg flacone | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | NOVARTISEUROPHARMLTD |
| Italy | (L01EG02) everolimus (neoplastic diseases) | AFINITOR*30 cpr 10 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NOVARTISEUROPHARMLTD |
| Italy | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS*30 cpr 10 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | MEDACPHARMASrl |
| Italy | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS*30 cpr 10 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | SANDOZGMBH |
| Italy | (L01EG02) everolimus (neoplastic diseases) | VOTUBIA*30 cpr dispers 2 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Tuberous Sclerosis | NOVARTISEUROPHARMLTD |
| Italy | (L01EG02) everolimus (neoplastic diseases) | VOTUBIA*30 cpr dispers 3 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Tuberous Sclerosis | NOVARTISEUROPHARMLTD |
| Italy | (L01EG02) everolimus (neoplastic diseases) | AFINITOR*30 cpr 5 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NOVARTISEUROPHARMLTD |
| Italy | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS*30 cpr 5 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | MEDACPHARMASrl |
| Italy | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS*30 cpr 5 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | SANDOZGMBH |
Pages
